Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which ...

T cells are a promising cancer therapy that are made from the patient's own T cells, which are reprogrammed to fight their ...

In a landmark achievement in cancer care, three patients treated with Chimeric Antigen Receptor T-cell (CAR T-cell) therapy for relapsed follicular lymphoma at Narayana Health City, Bengaluru, have ...

I n February 2025, it was revealed that a woman who as a child had undergone treatment for neuroblastoma was still ...

Inspired by advances in cancer therapy, a team at the Buck Institute has engineered immune cells equipped with specialized ...

Jacob E. Berchuck, MD, discusses research on plasma epigenomic profiling in metastatic castration-resistant prostate cancer.

The cure to cancer may not be hidden in some drug or chemical but within our own body. A team of Chinese researchers recently ...

To assess T-cell-induced morphological changes, each organoid was segmented in the transmitted light (TL) channel using a ...

For decades, vaccines have been seen as tools to prevent disease, protecting us from measles, flu, and even certain types of ...

Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...

Novel chemoimmunotherapy platform aims to transform outcomes in one of the world’s deadliest cancersNEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Medicovestor, Inc., a biotechnology company advancing ...

The BioNTech SE acquisition of CureVac N.V. brings together complementary technologies, as both are developing mRNA ...